0
0.5
1
1.5
2+
Symp. case
82%
Improvement
Relative Risk
Symp. case (b)
88%
Case
29%
HCQ for COVID-19 Raabe et al. Prophylaxis
Is pre-exposure prophylaxis with HCQ beneficial for COVID-19?
Prospective study of 130 patients in the USA
Fewer symptomatic cases with HCQ (not stat. sig., p=0.17)
c19hcq.org
Raabe et al., medRxiv, July 2022
Favors HCQ
Favors control